New Products: DigitalTRACE™ for dPCR Chimerism Monitoring and OrganTRACE® for Solid Organ Monitoring

We strive to offer our customers best in class solutions for post-transplant monitoring to improve the quality of life for transplant recipients. Our new products enable for a particularly sensitive chimerism monitoring and for a non-invasive solid organ health monitoring. Both products will facilitate earlier detection of the disease and allow the initiation of timely therapeutic intervention.

The DigitalTRACE™ Assays take advantage of the highly precise and sensitive digital PCR (dPCR) technology that allows accurate quantification using less sample. The total of 46 targets available offer a broad choice of informative assays and enable for an earlier detection of a relapse.

The OrganTRACE® Assays are specially designed to quantify donor-derived, cell-free DNA (dd-cfDNA) in the plasma of transplant recipients. Increased dd-cfDNA levels in general indicate acute graft rejection and timely detection of this event improves the chances on a good transplantation outcome.